Cytokinetics reported $-76516000 in EBITDA for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Acadia Pharmaceuticals ACAD:US $ -112.5M 68.38M
Acorda Therapeutics ACOR:US $ -4.97M 3.28M
Amgen AMGN:US $ 3341M 185M
Arca Biopharma ABIO:US $ -5.68M 1.58M
Biogen BIIB:US $ 674.7M 20.2M
Brainstorm Cell Therapeutics BCLI:US $ -5.4M 0.74M
Bristol Myers Squibb BMY:US $ 5772M 404M
Capricor Therapeutics CAPR:US $ -5.94M 2.84M
Cytokinetics CYTK:US $ -76.52M 58.35M
Eisai 4523:JP Y -11598M 35133M
Eli Lilly And LLY:US $ 3005.6M 161.6M
Exelixis EXEL:US $ 87.73M 30.84M
Genocea Biosciences GNCA:US $ -15.37M 2.37M
Geron GERN:US $ -28.62M 2.3M
Halozyme Therapeutics HALO:US $ 76.45M 19.11M
Intra Cellular Therapies ITCI:US $ -72.49M 13.37M
IONIS PHARMACEUT IONS:US $ -53.21M 278.25M
Ligand Pharmaceuticals LGND:US $ 4.35M 21.55M
Merk MRK:US $ 6179M 492M
Novartis NOVN:VX SF 4552M 346M
Pfizer PFE:US $ 11182M 4046M
Regeneron Pharmaceuticals REGN:US $ 1360.9M 1353.3M